Literature DB >> 11993538

Botulinum toxin for treatment of masseteric hypertrophy.

Andrew Che Fai Hui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11993538     DOI： 10.1007/s004150200017

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  The medical management of masseteric hypertrophy with botulinum toxin.

Authors:  S Finn; P Ryan; D Sleeman
Journal:  J Ir Dent Assoc       Date:  2000

Review 2.  Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report.

Authors:  L Mandel; M Tharakan
Journal:  J Oral Maxillofac Surg       Date:  1999-08       Impact factor: 1.895

Review 3.  Botulinum toxin: evidence-based medicine criteria in rare indications.

Authors:  W H Jost; A Kohl
Journal:  J Neurol       Date:  2001-04       Impact factor: 4.849

4.  Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.

Authors:  E K Tan; J Jankovic
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

5.  Botulinum toxin injection for the treatment of oromandibular dystonia.

Authors:  A Blitzer; M F Brin; P E Greene; S Fahn
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-02       Impact factor: 1.547

6.  A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement.

Authors:  E W To; A T Ahuja; W S Ho; W W King; W K Wong; P C Pang; A C Hui
Journal:  Br J Plast Surg       Date:  2001-04

7.  [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy].

Authors:  B A Rijsdijk; R J van ES; F W Zonneveld; M H Steenks; R Koole
Journal:  Ned Tijdschr Geneeskd       Date:  1998-03-07

8.  Treatment of oromandibular dystonia with botulinum toxin.

Authors:  N Hermanowicz; D D Truong
Journal:  Laryngoscope       Date:  1991-11       Impact factor: 3.325

9.  The medical management of masseteric hypertrophy with botulinum toxin type A.

Authors:  A P Moore; G D Wood
Journal:  Br J Oral Maxillofac Surg       Date:  1994-02       Impact factor: 1.651
  9 in total
  3 in total

1.  [Chemodenervation with botulinumtoxin in masseteric hypertrophy].

Authors:  R A Mischkowski; M Siessegger; F Lazar; J E Zöller
Journal:  Mund Kiefer Gesichtschir       Date:  2005-03

Review 2.  Botulinum toxin for masseter hypertrophy.

Authors:  Zbys Fedorowicz; Esther J van Zuuren; Jan Schoones
Journal:  Cochrane Database Syst Rev       Date:  2013-09-09

3.  Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.

Authors:  Fernanda Homem de Mello de Souza Klein; Fabiane Mulinari Brenner; Maurício Shigeru Sato; Fernanda Manfron Batista Rosas Robert; Karin Adriane Helmer
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.